{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

The spasticity survey has now closed

Thank you to all who participated, we’ve had almost 700 responses. The results will be written up in MS in focus, due out late summer. If you haven’t already signed up to the magazine and wish to do so, subscribe here.

Du Pré Grants and McDonald Fellowships: application deadline

The 30 June deadline is approaching for our Du Pré Grants and McDonald Fellowships applications.

read more

Global Economic Impact of MS project finalised

MSIF is delighted to announce that we have awarded the contract to develop the Global Economic Impact of MS project to RTI International.

read more

back to top

Profile of the Month : July 2008

Age: 38
Country: Italy
Occupation: Architect
Year of diagnosis: 1992
Type of MS: Secondary progressive

A world free from MS is not utopia

Read the full article here:
English Francais Espanol Italiano Deutsche Русский

back to top

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.

The authors looked at combination treatment with interferon beta 1a and atorvastatin in people with MS. Surprisingly they found that people who took both medications had more relapses and more activity on MRI.

authors: Birnbaum G, Cree B, Altafullah I, Zinser M, Reder AT.

source: Neurology. 2008 Jun 4. [Epub ahead of print]

read more

Fatigue, depression and progression in multiple sclerosis.

The authors investigated the link between fatigue and depression with disease progression in people with MS. They found that these symptoms remain stable within the individual over different stages of the disease.

authors: Koch M, Uyttenboogaart M, van Harten A, Heerings M, De Keyser J.

source: Mult Scler. 2008 Jun 5. [Epub ahead of print]

read more

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses.

In this negative study, the authors looked to see if contrast enhancing lesions on MRI predicted clinical relapses during the following year in people with MS. They concluded that they were not useful as predictors.

authors: Petkau J, Reingold SC, Held U, Cutter GR, Fleming TR, Hughes MD, Miller DH, McFarland HF, Wolinsky JS.

source: Mult Scler. 2008 Jun 5. [Epub ahead of print]

read more

Abnormalities in the cerebrospinal fluid levels of endocannabinoids in Multiple Sclerosis.

The authors investigated the role of endocannabinoids which are molecules involved in inflammation, in the pathogenesis of MS. They found low levels of them in the spinal fluid of people with MS and the levels varied depending on the activity of the disease, which may suggest a role in limiting inflammation.

authors: Di Filippo M, Pini LA, Pelliccioli GP, Calabresi P, Sarchielli P.

source: J Neurol Neurosurg Psychiatry. 2008 Jun 5. [Epub ahead of print]

read more

Relapses in multiple sclerosis are age and time-dependent.

The authors retrospectively studied relapse rate in people with relapsing-remitting MS over 20 years. They found that the number of relapses decreased with age and over time, which may be useful when deciding on timing of treatment.

authors: Tremlett H, Zhao Y, Joseph J, Devonshire V.

source: J Neurol Neurosurg Psychiatry. 2008 Jun 5. [Epub ahead of print]

read more

back to top

Spain: Annual swimathon for MS

Spain’s national fundraising and awareness event for people with MS, ‘Mójate por la EM – get wet for MS’, is happening on 13 July.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.